에드워드 생명과학 주식회사
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionEvermay Wealth Management Llc
Latest Disclosed Ownership2,894 shares
Latest Disclosed Value $ 231,752
Evermay Wealth Management Llc reports 12.41% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 11, 2026 - Evermay Wealth Management Llc filed a 13F-HR form disclosing ownership of 2,894 shares of Edwards Lifesciences Corporation (MX:EW) valued at $231,752 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 3,304 shares of Edwards Lifesciences Corporation. This represents a change in shares of -12.41% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,894 -410 -12.41 232 -17.79 0.0257
2026-01-22 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,304 128 4.03 282 14.23 0.0316
2025-11-05 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,176 193 6.47 247 5.58 0.0282
2025-07-30 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,983 156 5.52 233 14.22 0.0287
2025-05-07 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,827 253 9.83 205 7.37 0.0269
2025-01-24 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,574 -798 -23.67 191 -14.41 0.0289
2024-10-25 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,372 2,625 351.41 223 221.74 0.0358
2024-08-01 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 747 725 3,295.45 69 3,350.00 0.0111
2024-05-14 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 22 -81 -78.64 2 -71.43 0.0003
2024-02-12 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 103 6 6.19 8 16.67 0.0015
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 97 75 340.91 7 200.00 0.0014
2023-08-10 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 22 22 2 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.